|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 39/395 | (2006.01) |
| A61K 31/506 | (2006.01) | ||
| A61K 31/7072 | (2006.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 43/00 | (2006.01) | ||
| A61K 31/513 | (2006.01) | ||
| C07K 16/22 | (2006.01) | ||
| C07K 16/28 | (2006.01) | ||
| A61K 39/00 | (2006.01) |
| (11) | Number of the document | 3042669 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14842538.2 |
| Date of filing the European patent application | 2014-09-05 | |
| (97) | Date of publication of the European application | 2016-07-13 |
| (45) | Date of publication and mention of the grant of the patent | 2023-03-08 |
| (46) | Date of publication of the claims translation | 2023-06-26 |
| (86) | Number | PCT/JP2014/073436 |
| Date | 2014-09-05 |
| (87) | Number | WO 2015/034032 |
| Date | 2015-03-12 |
| (30) | Number | Date | Country code |
| 2013184684 | 2013-09-06 | JP |
| (72) |
OKABE, Hiroyuki , JP
|
| (73) |
Taiho Pharmaceutical Co., Ltd. ,
1-27, Kandanishiki-cho, Chiyoda-ku
Tokyo 101-8444,
JP
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Priešvėžinis agentas ir stipriklis su priešvėžiniu poveikiu |
| ANTITUMOR AGENT AND ANTITUMOR EFFECT ENHANCER |
| Payment date | Validity (years) | Amount | |
| 2025-08-04 | 12 | 289.00 EUR |
| 2026-09-05 |